Predictors of Differential Response to Induction Therapy in High-Risk Neuroblastoma: A Report from the Children’s Oncology Group (COG)

Tekijä Pinto, Navin, Naranjo, Arlene, Hibbitts, Emily, Kreissman, Susan G., Granger, M. Meaghan, Irwin, Meredith S., Bagatell, Rochelle, London, Wendy B., Greengard, Emily G., Park, Julie R., DuBois, Steven G.
Julkaisussa Eur J Cancer (2019)

Association of MYCN Copy Number with Clinical Features, Tumor Biology, and Outcomes in Neuroblastoma: A Report from the Children’s Oncology Group

Tekijä Campbell, Kevin, Gastier-Foster, Julie M., Mann, Meegan, Naranjo, Arlene, Van Ryn, Collin, Bagatell, Rochelle, Matthay, Katherine K., London, Wendy B., Irwin, Meredith S., Shimada, Hiroyuki, Granger, M. Meaghan, Hogarty, Michael D., Park, Julie R., DuBois, Steven G.
Julkaisussa Cancer (2017)

Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer

Tekijä Mack, Jennifer W., Uno, Hajime, Twist, Clare J., Bagatell, Rochelle, Rosenberg, Abby R., Marachelian, Araz, Granger, M. Meaghan, Bender, Julia Glade, Baker, Justin N., Park, Julie R., Cohn, Susan L., Fernandez, Jorge H., Diller, Lisa R., Shusterman, Suzanne
Julkaisussa J Pain Symptom Manage (2020)

Unrealistic Parental Expectations for Cure in Poor-Prognosis Childhood Cancer

Tekijä Mack, Jennifer W., Cronin, Angel M., Uno, Hajime, Shusterman, Suzanne, Twist, Clare J., Bagatell, Rochelle, Rosenberg, Abby, Marachelian, Araz, Granger, M. Meaghan, Bender, Julia Glade, Baker, Justin N., Park, Julie, Cohn, Susan L., Levine, Alyssa, Taddei, Sarah, Diller, Lisa R.
Julkaisussa Cancer (2019)

Phase 1 Study of Vorinostat as a Radiation Sensitizer with (131)I-Metaiodobenzylguanidine ((131)I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

Tekijä DuBois, Steven G., Groshen, Susan, Park, Julie R., Haas-Kogan, Daphne A., Yang, Xiaodong, Geier, Ethan, Chen, Eugene, Giacomini, Kathy, Weiss, Brian, Cohn, Susan L., Granger, M. Meaghan, Yanik, Gregory A., Hawkins, Randall, Courtier, Jesse, Jackson, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Czarnecki, Scarlett, Tsao-Wei, Denice, Villablanca, Judith G., Marachelian, Araz, Matthay, Katherine K.
Julkaisussa Clin Cancer Res (2015)

Phase 2 Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

Tekijä DuBois, Steven G., Mosse, Yael P., Fox, Elizabeth, Kudgus, Rachel A., Reid, Joel M., McGovern, Renee, Groshen, Susan, Bagatell, Rochelle, Maris, John M., Twist, Clare J., Goldsmith, Kelly, Granger, M. Meaghan, Weiss, Brian, Park, Julie R., Macy, Margaret E., Cohn, Susan L., Yanik, Greg, Wagner, Lars, Hawkins, Randall, Courtier, Jesse, Lai, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Boucher, Najee, Czarnecki, Scarlett, Luo, Chunqiao, Tsao-Wei, Denice D., Matthay, Katherine K., Marachelian, Araz
Julkaisussa Clin Cancer Res (2018)